• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症伴 ATXN2 中间重复扩展病例的小脑神经元丢失。

Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.

机构信息

Neuroscience Research Australia, Sydney, Australia.

School of Medical Sciences, University of New South Wales, Sydney, Australia.

出版信息

Ann Neurol. 2016 Feb;79(2):295-305. doi: 10.1002/ana.24565. Epub 2016 Jan 14.

DOI:10.1002/ana.24565
PMID:26599997
Abstract

OBJECTIVE

Despite evidence suggesting that the cerebellum may be targeted in amyotrophic lateral sclerosis (ALS), particularly in cases with repeat expansions in the ATXN2 and C9ORF72 genes, the integrity of cerebellar neurons has yet to be examined. The present study undertakes a histopathological analysis to assess the impact of these repeat expansions on cerebellar neurons and determine whether similar cerebellar pathology occurs in sporadic disease.

METHODS

Purkinje and granule cells were quantified in the vermis and lateral cerebellar hemispheres of ALS cases with repeat expansions in the ATXN2 and C9ORF72 genes, sporadic disease, and sporadic progressive muscular atrophy with only lower motor neuron degeneration.

RESULTS

ALS cases with intermediate repeat expansions in the ATXN2 gene demonstrate a significant loss in Purkinje cells in the cerebellar vermis only. Despite ALS cases with expansions in the C9ORF72 gene having the highest burden of inclusion pathology, no neuronal loss was observed in this group. Neuronal numbers were also unchanged in sporadic ALS and sporadic PMA cases.

INTERPRETATION

The present study has established a selective loss of Purkinje cells in the cerebellar vermis of ALS cases with intermediate repeat expansions in the ATXN2 gene, suggesting a divergent pathogenic mechanism independent of upper and lower motor neuron degeneration in ALS. We discuss these findings in the context of large repeat expansions in ATXN2 and spinocerebellar ataxia type 2, providing evidence that intermediate repeats in ATXN2 cause significant, albeit less substantial, spinocerebellar damage compared with longer repeats in ATXN2.

摘要

目的

尽管有证据表明小脑可能是肌萎缩侧索硬化症(ALS)的靶点,特别是在 ATXN2 和 C9ORF72 基因重复扩展的情况下,但小脑神经元的完整性尚未得到检查。本研究进行了组织病理学分析,以评估这些重复扩展对小脑神经元的影响,并确定是否在散发性疾病中发生类似的小脑病变。

方法

在 ATXN2 和 C9ORF72 基因重复扩展的 ALS 病例、散发性疾病和仅有下运动神经元退变的散发性进行性肌萎缩症中,对小脑蚓部和外侧小脑半球的浦肯野和颗粒细胞进行了量化。

结果

ATXN2 基因中间重复扩展的 ALS 病例仅在小脑蚓部显示浦肯野细胞明显丢失。尽管 C9ORF72 基因扩展的 ALS 病例具有最高的包涵体病理负担,但在该组中未观察到神经元丢失。在散发性 ALS 和散发性 PMA 病例中,神经元数量也没有变化。

解释

本研究确立了 ATXN2 基因中间重复扩展的 ALS 病例中小脑蚓部浦肯野细胞的选择性丢失,表明与 ALS 中上下运动神经元退变无关的不同致病机制。我们在 ATXN2 中的大重复扩展和脊髓小脑性共济失调 2 型的背景下讨论了这些发现,提供了证据表明 ATXN2 中的中间重复导致明显但不那么实质性的脊髓小脑损伤,与 ATXN2 中的较长重复相比。

相似文献

1
Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.肌萎缩侧索硬化症伴 ATXN2 中间重复扩展病例的小脑神经元丢失。
Ann Neurol. 2016 Feb;79(2):295-305. doi: 10.1002/ana.24565. Epub 2016 Jan 14.
2
TDP-43 levels in the brain tissue of ALS cases with and without or gene expansions.TDP-43 在伴有和不伴有 或 基因扩增的 ALS 病例脑组织中的水平。
Neurology. 2019 Nov 5;93(19):e1748-e1755. doi: 10.1212/WNL.0000000000008439. Epub 2019 Oct 16.
3
C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.印度肌萎缩侧索硬化症患者中C9orf72六核苷酸重复序列扩增和共济失调蛋白2中间长度重复序列扩增
Neurobiol Aging. 2017 Aug;56:211.e9-211.e14. doi: 10.1016/j.neurobiolaging.2017.04.011. Epub 2017 Apr 26.
4
Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.与共济失调蛋白2中长度中等的CAG重复序列扩增相关的运动神经元病/肌萎缩侧索硬化症不存在1C2阳性的聚谷氨酰胺包涵体。
Neuropathol Appl Neurobiol. 2016 Jun;42(4):377-89. doi: 10.1111/nan.12254. Epub 2015 Jul 7.
5
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.在携带C9ORF72基因GGGGCC重复扩增的意大利肌萎缩侧索硬化症患者中,ATNX2不是一个调控基因。
Neurobiol Aging. 2016 Mar;39:218.e5-8. doi: 10.1016/j.neurobiolaging.2015.11.027. Epub 2015 Dec 8.
6
ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.ATXN2-AS是与ATXN2基因互补的反义基因,与2型脊髓小脑共济失调和肌萎缩侧索硬化症相关。
Ann Neurol. 2016 Oct;80(4):600-15. doi: 10.1002/ana.24761.
7
C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.C9orf72和ATXN2重复序列扩增在一个患有共济失调、痴呆和帕金森症的家族中共存。
Mov Disord. 2017 Jan;32(1):158-162. doi: 10.1002/mds.26841. Epub 2016 Nov 7.
8
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.由 ataxin-2 中间多聚谷氨酰胺扩展引起的肌萎缩侧索硬化症风险的调节是一种特异性效应。
Neurobiol Dis. 2012 Jan;45(1):356-61. doi: 10.1016/j.nbd.2011.08.021. Epub 2011 Aug 25.
9
Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.ATXN2 中的中等长度 CAG 重复与巴西患者肌萎缩侧索硬化症的风险增加相关。
Neurobiol Aging. 2018 Sep;69:292.e15-292.e18. doi: 10.1016/j.neurobiolaging.2018.04.020. Epub 2018 May 8.
10
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.扩张的 ATXN2 CAG 重复序列大小在 ALS 中鉴定出 ALS 和 SCA2 之间的遗传重叠。
Neurology. 2011 Jun 14;76(24):2066-72. doi: 10.1212/WNL.0b013e31821f445b. Epub 2011 May 11.

引用本文的文献

1
Perspectives in Amyotrophic Lateral Sclerosis: Biomarkers, Omics, and Gene Therapy Informing Disease and Treatment.肌萎缩侧索硬化症的展望:生物标志物、组学及为疾病与治疗提供信息的基因疗法
Int J Mol Sci. 2025 Jun 13;26(12):5671. doi: 10.3390/ijms26125671.
2
Multi-region brain transcriptomic analysis of amyotrophic lateral sclerosis reveals widespread RNA alterations and substantial cerebellum involvement.肌萎缩侧索硬化症的多区域脑转录组分析揭示了广泛的RNA改变和小脑的大量受累。
Mol Neurodegener. 2025 Apr 25;20(1):40. doi: 10.1186/s13024-025-00820-5.
3
TMEM106B deficiency leads to alterations in lipid metabolism and obesity in the TDP-43 knock-in mouse model.
在TDP-43基因敲入小鼠模型中,跨膜蛋白106B(TMEM106B)缺乏导致脂质代谢改变和肥胖。
Commun Biol. 2025 Feb 26;8(1):315. doi: 10.1038/s42003-025-07752-2.
4
Cerebellum in neurodegenerative diseases: Advances, challenges, and prospects.神经退行性疾病中的小脑:进展、挑战与展望
iScience. 2024 Oct 18;27(11):111194. doi: 10.1016/j.isci.2024.111194. eCollection 2024 Nov 15.
5
ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes.ATAXIN-2 中间长度多聚谷氨酰胺扩展引起 ALS 相关代谢和免疫表型。
Nat Commun. 2024 Aug 29;15(1):7484. doi: 10.1038/s41467-024-51676-0.
6
Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier.阿尔茨海默病及其他神经退行性疾病中的小脑:一个新兴的研究前沿。
MedComm (2020). 2024 Jul 13;5(7):e638. doi: 10.1002/mco2.638. eCollection 2024 Jul.
7
Intermediate Repeat Expansion in the Gene as a Risk Factor in the ALS and FTD Spanish Population.基因中的中间重复序列扩增作为西班牙人群肌萎缩侧索硬化症和额颞叶痴呆的一个风险因素。
Biomedicines. 2024 Feb 2;12(2):356. doi: 10.3390/biomedicines12020356.
8
Guggulsterone Selectively Modulates STAT-3, mTOR, and PPAR-Gamma Signaling in a Methylmercury-Exposed Experimental Neurotoxicity: Evidence from CSF, Blood Plasma, and Brain Samples.古古甾酮在甲基汞暴露所致实验性神经毒性中对信号转导及转录激活因子3、哺乳动物雷帕霉素靶蛋白和过氧化物酶体增殖物激活受体γ信号通路具有选择性调节作用:来自脑脊液、血浆和脑样本的证据
Mol Neurobiol. 2024 Aug;61(8):5161-5193. doi: 10.1007/s12035-023-03902-x. Epub 2024 Jan 3.
9
MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns.磁共振成像聚类分析揭示了具有独特神经退行性变模式的三种肌萎缩侧索硬化症亚型。
Ann Neurol. 2022 Dec;92(6):1030-1045. doi: 10.1002/ana.26488. Epub 2022 Sep 20.
10
The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review.脑库对肌萎缩侧索硬化症知识发现的贡献:系统评价。
Neuropathol Appl Neurobiol. 2022 Dec;48(7):e12845. doi: 10.1111/nan.12845. Epub 2022 Aug 18.